APOC3 and hypertriglyceridemia: In hypertriglyceridemia caused by elevated ApoC-III levels, the VLDL concentration in plasma increases due to a dual impact of ApoC-III: (i) decreased LPL activity and (ii) enhanced synthesis and hepatic secretion of VLDL.